Ocugen, Inc.
(NASDAQ : OCGN)

( )
OCGN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 4.33%154.810.0%$1916.35m
NVAXNovavax, Inc. 4.39%231.2392.9%$1445.79m
OCGNOcugen, Inc. 36.88%10.950.0%$1181.32m
AMGNAmgen, Inc. -1.14%224.921.3%$593.58m
ILMNIllumina, Inc. -1.45%439.413.5%$546.96m
REGNRegeneron Pharmaceuticals, Inc. -0.58%450.572.7%$528.56m
VRTXVertex Pharmaceuticals, Inc. -0.20%212.551.9%$509.80m
GILDGilead Sciences, Inc. -2.21%61.401.0%$483.93m
BNGOBioNano Genomics, Inc. -2.89%9.730.0%$394.84m
ALXNAlexion Pharmaceuticals, Inc. -0.59%152.752.0%$382.70m
BIIBBiogen, Inc. -1.58%272.881.7%$374.45m
CRSPCRISPR Therapeutics AG -1.25%125.690.6%$298.18m
EXASEXACT Sciences Corp. 3.67%136.1218.4%$255.24m
SRNESorrento Therapeutics, Inc. -4.45%9.671.3%$229.08m
VXRTVaxart, Inc. -4.67%7.150.0%$213.63m

Company Profile

Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline includes OCU400, OCU410, OCU200, OCU200, and OCU300. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA.